Delivery Order SPE2DB22D2108-SPE2DB24FU3PV
Award Date 4/1/24
Potential Completion Date 4/2/24
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.72 firm fixed-price delivery order is for the supply of 4,567,765,529 dextroamphetamine 10 mg tablets in 100-count bottles. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,487.04 firm fixed-price contract is for the delivery of 4565784452 - dextroamphetamine-amphetamine 10 mg tablets, with a completion date of September 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,044.18, is for the delivery of 4,564,070,549 units of Dextroamphetamine-Amphetamine 10 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,653.71 order is for the supply of dextroamphetamine-amphetamine 10 mg tablets, to be delivered by January 30, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00, which serves as the primary vehicle for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100 count) on September 4, 2025, with a ceiling value of $1,034.62 and completion date of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $2,724.25 award is for the supply of Dextroamphetamine-Amphetamine 10 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. The order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp that has a potential value of $999,999,999.00 and runs through...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,388.90 contract is for the supply of dextroamphetamine-amphetamine 15 mg tablets in 100-count bottles. The award has an ultimate completion date of July 18, 2024 and is not a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999, which...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The award is for the delivery of 10 milligram dextroamphetamine-amphetamine capsules in 100 count packages, with a total ceiling value of $1,555.52 and a period of performance through March 22, 2024. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,587,469 capsules of dextroamphetamine-amphetamine 30 mg. The contract has a ceiling value of $1,664.22 and a period of performance through May 14, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,271.67 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 27, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB24FU3PVDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,351.44 order is for the supply of 4,564,135,160 tablets of dextroamphetamine-amphetamine 10 mg, with an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was not set aside and is issued under the terms of the IDC.
Generated 7/1/24, 9:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/1/24 |